A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome.
Valeria CognigniEnrica CapellettoPaola BordiValeria PaveseFederica Maria CarfìFrancesco GelsominoAndrea De GiglioRita ChiariRoberta MinariEnrico AmbrosiniAntonio PercesepeDaniela GiachinoPaolo BironzoMarcello TiseoPublished in: Tumori (2024)
and HER family receptor tyrosine kinases remains unclear, but an extensive molecular characterization of tumors from patients with Li Fraumeni syndrome should always be performed, to offer patients a personalized therapeutic approach.